
How AZ and Amgen’s Tezspire respiratory data ups the ‘level of ambition’ in immunology
What do you get when you combine the efforts of one of the world’s leading respiratory drugmakers with a global pioneer in biological medicines? You get a next-gen treatment like Tezspire, which according to pivotal results revealed this month, could …